应用深度学习于Gd-EOB-DTPA增强MRI自动检测肝硬化肝脏中的小肝细胞癌
本回顾性研究纳入120例肝硬化患者(78例小肝细胞癌,42例非肝细胞癌肝硬化),按8:2分为训练集和测试集,采用nnU-Net深度学习模型在Gd-EOB-DTPA增强MRI上检测小肝细胞癌。病灶水平鉴别小肝细胞癌与非肝细胞癌的AUC在训练集为0.967、测试集为0.864(P<0.001);病例水平训练集和测试集的准确率分别为92.5%和81.5%,敏感度分别为95.1%和88.2%,特异度分别为87.5%和70%。结论认为该深度学习方法在肝硬化患者中检测小肝细胞癌有效。
要点
- 病灶水平鉴别小肝细胞癌与非肝细胞癌的AUC训练集0.967、测试集0.864(P<0.001)。
- 病例水平检测小肝细胞癌的敏感度训练集95.1%、测试集88.2%。
- 病例水平检测小肝细胞癌的特异度训练集87.5%、测试集70%。
核心结论
- 深度学习方法在肝硬化患者队列中检测小肝细胞癌显示出有效性。
研究设计与样本
- 回顾性研究,纳入120例肝硬化患者(78例小肝细胞癌,42例非肝细胞癌肝硬化),采用分层抽样,按8:2比例分为训练集和测试集;使用nnU-Net模型,基于Gd-EOB-DTPA增强MRI,以Dice系数评估分割性能,以ROC曲线、AUC评分和P值评估鉴别能力。
诊断标准与关键数值
- 病灶水平鉴别小肝细胞癌与非肝细胞癌的AUC:训练集0.967,测试集0.864,均P<0.001。
- 病例水平检测小肝细胞癌的准确率:训练集92.5%(95% CI,85.1-96.9%),测试集81.5%(95% CI,61.9-93.7%)。
- 病例水平检测小肝细胞癌的敏感度:训练集95.1%(95% CI,86.3-99.0%),测试集88.2%(95% CI,63.6-98.5%)。
- 病例水平检测小肝细胞癌的特异度:训练集87.5%(95% CI,71.0-96.5%),测试集70%(95% CI,34.8-93.3%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop an automated deep learning (DL) methodology for detecting small hepatocellular carcinoma (sHCC) in cirrhotic livers, leveraging Gd-EOB-DTPA-enhanced MRI.
METHODS: The present retrospective study included a total of 120 patients with cirrhosis, comprising 78 patients with sHCC and 42 patients with non-HCC cirrhosis, who were selected through stratified sampling. The dataset was divided into training and testing sets (8:2 ratio). The nnU-Net exhibits enhanced capabilities in segmenting small objects. The segmentation performance was assessed using the Dice coefficient. The ability to distinguish between sHCC and non-HCC lesions was evaluated through ROC curves, AUC scores and P values. The case-level detection performance for sHCC was evaluated through several metrics: accuracy, sensitivity, and specificity.
RESULTS: The AUCs for distinguishing sHCC patients from non-HCC patients at the lesion level were 0.967 and 0.864 for the training and test cohorts, respectively, both of which were statistically significant at P < 0.001. At the case level, distinguishing between patients with sHCC and patients with cirrhosis resulted in accuracies of 92.5% (95% CI, 85.1-96.9%) and 81.5% (95% CI, 61.9-93.7%), sensitivities of 95.1% (95% CI, 86.3-99.0%) and 88.2% (95% CI, 63.6-98.5%), and specificities of 87.5% (95% CI, 71.0-96.5%) and 70% (95% CI, 34.8-93.3%) for the training and test sets, respectively.
CONCLUSION: The DL methodology demonstrated its efficacy in detecting sHCC within a cohort of patients with cirrhosis.
引用
- Lei J, Xu Y, Zhu Y, et al. Automated detection of small hepatocellular carcinoma in cirrhotic livers: applying deep learning to Gd-EOB-DTPA-enhanced MRI. Abdom Radiol (NY). 2025. PMID: 40059243. doi:10.1007/s00261-025-04853-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。